(via TheNewswire)
Revenue grew by 55%, quarter-over-quarter,
for the period ending
Financial Highlights (all amounts expressed in US dollars unless otherwise noted)
- Revenue for the three-month period ended
- Gross profit for the three-month period ended
- Total expenses for the three-month period ended
- Net loss for the three-month period ended
- Total assets for the period ended
Management Commentary
“I am pleased with G6’s increase in revenue over the last quarter and significant improvement in the Company’s gross profit and net loss position relative to the last three-month period. Also, G6’s cash balance and level of total assets is the strongest that it’s been in a very long time,” said
Summary of Key Quarterly Financial Measures
(all amounts expressed in US dollars unless otherwise noted, with 1Q21 shown for year-over-year comparison purposes)
------------------------------------------------------------------------------- | |Quarter |Quarter |Quarter |Quarter |Quarter | | |ended |ended |ended |ended |ended | | |Aug 31, |May 31, |Feb 28, |Nov 30, |Aug 31, | | |2021 |2021 |2021 |2020 |2020 | | |$ |$ |$ |$ |$ | |-----------------------------------------------------------------------------| |Revenue |341,134 |220,672 |263,425 |506,140 |949,426 | |-----------------------------------------------------------------------------| |Cost of goods sold |(169,652)|(478,223)|(193,993)|(237,236)|(512,818)| |-----------------------------------------------------------------------------| |Gross profit |171,482 |(257,551)|69,432 |268,904 |436,608 | |-----------------------------------------------------------------------------| |Operating expenses |(742,676)|(642,057)|(476,373)|(530,525)|(301,554)| |-----------------------------------------------------------------------------| |Other income/ (expenses) |- -- |83,300 |- |220,000 | |-----------------------------------------------------------------------------| |Net income (loss) |(571,194)|(899,609)|(323,641)|(261,621)|355,554 | |-----------------------------------------------------------------------------| |Comprehensive income (loss)|(747,028)|(407,455)|(321,152)|(320,759)|340,765 | |-----------------------------------------------------------------------------| |Net income (loss) per |($0.002 ) |($0.008 ) |($0.002 ) |($0.002 ) |$0.002 | |share (basic and | | | | | | |diluted) | | | | | | |-----------------------------------------------------------------------------| |Total assets |8,034,770|5,912,649|1,617,187|1,342,561|1,472,872| |-----------------------------------------------------------------------------| |Shareholders’ equity |7,538,004|5,525,214|836,567 |802,039 |855,942 | -------------------------------------------------------------------------------
Subsequent Highlighted Events(all amounts expressed in US dollars unless otherwise noted)
- Air Purifier Prototype Reduced Pathogenic Microorganisms by 99.9% in Antimicrobial Efficacy Test: On
- CEO Letter to Shareholders: On
- Updated Corporate Website and Investor Presentation: On
About
G6 has identified new graphene-based applications to accelerate growth into the future. Accordingly, the Company has a valuable IP portfolio currently comprised of five granted patents. The Company’s management team and employees have a deep understanding of graphene technology based on decades of aggregate academic and commercial experience.
The Company’s e-commerce websites are listed below:
- Conductive Epoxies: Adhesive materials distributed under the G6-EpoxyTMtrade name and can be purchased at www.g6-epoxy.com
- R&D Materials:
Graphene Laboratories Inc. currently offers over 100 graphene and related products available atwww.graphene-supermarket.com
Forward-Looking Information
This news release contains forward-looking statementswithin the meaning of the applicable securities legislation that is based on expectations, estimates and projections as at the date of this news release.Bytheir nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. “Forward-looking information” in this news release includes but is not limited to information about the graphene-enhanced air purifier (including efficacy and potential commercialization thereof); information about the potential for the Company’s long-term growth; the business goals and objectives of the Company, and other forward-looking information concerning the intentions, plans and future actions of the parties to the transactions described herein and the terms thereon.
The forward-looking information in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein.
Risk factors that could cause actual results to differ materially include, but are not limited to, the risk that actual results in commercial applications of the graphene-enhanced air purifier may differ significantly from the Test Results; the Test Results may not be accepted by applicable regulatory agencies required to approve commercialization of the graphene-enhanced air purifier; the Company may not receive required approvals from regulatory agencies to commercialize the graphene-enhanced air purifier; the Company may not achieve further stages of commercialization of the graphene-enhanced air purifier as anticipated, or at all;risks associated with adoption by industries of graphene-based products health and environmental factors affecting adoption of these technologies; the company may fail to obtain appropriate government approvals or accreditation related to the business’ operations and technological processes; the results of the tests being performed by an independent laboratory may be unsatisfactory and prevent the company from receiving government approvals and accreditations; the market conditions and demand for its product as well as the market prices of such products being developed by the company may change over time; reliance on key personnel; the potential for conflicts of interest among certain officers, directors or promoters with certain other projects; competition; dilution; and the volatility of our common share price and volume.
The Company undertakes no obligation to revise or update any forward-looking information other than as required by law.
Neither
Commercial Inquiries
Telephone: (631) 405-5113
Email:info@g6-materials.com
Investor Inquiries
G6 Investor Relations
Telephone: (631) 405-5114
Email:investors@g6-materials.com
ON BEHALF OF THE BOARD: Daniel Stolyarov, President & CEO
SOURCE:
For more information on
Copyright (c) 2021 TheNewswire - All rights reserved.
Copyright (c) 2021 TheNewswire - All rights reserved., source